Search images on Google      Product Monograph

Active Ingredients:

• omalizumab, 150 MG/1 ML

DIN: 02459795

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: PREFILLED SYRINGE

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC  –  official site

ATC:

• R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO, Wiki)
• R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO)
• R03DX - Other systemic drugs for obstructive airway diseases (ATC, WHO)
• R03DX05 - OMALIZUMAB (WHO)

Reference brand drug: Xolair

 

External Links for Xolair:

Search on Google

• Xolair side effects
• Xolair dosage
• omalizumab side effects
• omalizumab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find xolair photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.